LOGO
LOGO

TODAY'S TOP STORIES

Pre-market Movers: CTNT, NLSP, PSQH, JANX, CHRS…

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024 lt

The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).

In the Green

Cheetah Net Supply Chain Service Inc. (CTNT) is up over 267% at $6.91.
NLS Pharmaceutics AG (NLSP) is up over 113% at $6.61.
PSQ Holdings, Inc. (PSQH) is up over 90% at $3.92.
Janux Therapeutics, Inc. (JANX) is up over 70% at $68.50.
Coherus BioSciences, Inc. (CHRS) is up over 44% at $1.98.
Shimmick Corporation (SHIM) is up over 40% at $3.93.
Credo Technology Group Holding Ltd (CRDO) is up over 32% at $63.25.
Citius Oncology, Inc. (CTOR) is up over 31% at $1.34.
Vir Biotechnology, Inc. (VIR) is up over 24% at $10.15.
Graphjet Technology (GTI) is up over 14% at $2.88.
Jeffs' Brands Ltd (JFBR) is up over 10% at $2.85.

In the Red

Logistic Properties of the Americas (LPA) is down over 23% at $9.96.
Gelteq Limited (GELS) is down over 21% at $2.99.
indie Semiconductor, Inc. (INDI) is down over 17% at $4.35.
Sharps Technology, Inc. (STSS) is down over 16% at $2.85.
JE Cleantech Holdings Limited (JCSE) is down over 15% at $1.52.
Unusual Machines, Inc. (UMAC) is down over 13% at $13.00.
Vision Marine Technologies Inc. (VMAR) is down over 12% at $1.74.
Snail, Inc. (SNAL) is down over 8% at $1.31.
Founder Group Limited (FGL) is down over 7% at $3.96.
CleanSpark, Inc. (CLSK) is down over 6% at $13.54.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19